ST. John's University
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Nov 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Feb 8 to 28, 2027 · next Feb 8
- 1 fee due Mar 26, 2027The maintenance fee for Circulating serum cell-free DNA biomarkers and methods (US 11,767,562) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 19, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,717,499 | Administration of N,n-Dimethylacetamide for the Treatment of Preterm Birth In force · High confidence | In force | High confidence | |
| US 10,166,197 | Sugar Ester Nanoparticle Stabilizers In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 10,762,544 | Issue Resolution Utilizing Feature Mapping In force · High confidence | In force | High confidence | |
| US 11,499,184 | Circulating Serum Microrna Biomarkers and Methods In force · High confidence | In force | High confidence | |
| US 12,729,398 | Circulating Serum Microrna Biomarkers and Methods In force · High confidence | In force | High confidence | |
| US 12,398,427 | Circulating serum microRNA biomarkers and methods for Alzheimer's disease diagnosis In force · From the USPTO record | In force | From the USPTO record | |
| US 11,634,775 | Circulating Serum Microrna Biomarkers and Methods for Alzheimer's Disease Diagnosis In force · High confidence | In force | High confidence | |
| US 12,448,653 | Circulating Serum Microrna Biomarkers and Methods for Parkinson's Disease Prognosis In force · High confidence | In force | High confidence | |
| US 11,767,562 | Circulating serum cell-free DNA biomarkers and methods In force · From the USPTO record | In force | From the USPTO record | |
| US 12,146,194 | Circulating serum cell-free DNA biomarkers and methods In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 13: 6 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 6 no status recorded